APEX Biologix Enters Into Agreement with Mayo Clinic

APEX Biologix entered into a know-how license agreement with Mayo Clinic to jointly develop new regenerative medicine products.

Under the agreement, Mayo Clinic will license its know-how to APEX Biologix, enabling the two organizations to collaborate on the development of new therapies that can potentially transform the treatment of...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

  • This field is for validation purposes and should be left unchanged.

0